<DOC>
	<DOC>NCT00562120</DOC>
	<brief_summary>An H3 receptor antagonist should reduce the congestion associated with allergic rhinitis. A nasal allergen challenge will be given to patients to induce rhinitis symptoms and acoustic rhinometry will be used to measure the congestion.</brief_summary>
	<brief_title>A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>Male or female subjects 1955 years with allergic rhinitis requiring treatment within the previous 2 years. Subjects that respond to a ragweed nasal allergen challenge at screening. History of asthma or FEV1 &lt; 80% predicted. Significant concomitant disease or medications. Symptoms of allergic rhinitis within 2 weeks prior to screening.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>